上海莱士：部分董事及全体高级管理人员拟合计增持不低于600万元股份

Group 1 - The company Shanghai Laishi (SZ 002252) announced that several executives, including the vice chairman and general manager, plan to increase their shareholding by at least 6 million RMB within six months using self-raised funds [1] - As of the first half of 2025, the company's revenue composition shows that blood product production and sales account for 99.21%, while testing equipment and reagents account for 0.76%, and other businesses account for 0.03% [1] - The current market capitalization of Shanghai Laishi is 44.9 billion RMB [1]